Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 14, 2017 05:55 ET | Source: H. Lundbeck A/S

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Valby, Denmark, 2017-08-14 11:55 CEST (GLOBE NEWSWIRE) -- Valby, Denmark, 14 August 2017 – H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely...
August 10, 2017 09:09 ET | Source: H. Lundbeck A/S

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Valby, Denmark, 2017-08-10 15:09 CEST (GLOBE NEWSWIRE) -- Valby, Denmark, 10 August 2017 – H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely...
August 10, 2017 09:09 ET | Source: H. Lundbeck A/S

Ledende medarbejderes og deres nærtståendes transaktioner med aktier og tilknyttede værdipapirer i H. Lundbeck A/S

Valby, Danmark, 2017-08-10 15:09 CEST (GLOBE NEWSWIRE) -- Valby, Danmark, 10. august 2017 - H. Lundbeck A/S (Lundbeck) skal herved offentliggøre og indberette ledende medarbejderes og disses...
August 09, 2017 00:55 ET | Source: H. Lundbeck A/S

Lundbeck reports 13% revenue growth and a doubling of EBIT in first half of 2017

Valby, Denmark, 2017-08-09 06:55 CEST (GLOBE NEWSWIRE) -- HIGHLIGHTS Revenue reached DKK 8,494 million in the first six months of 2017 representing an increase of 13% compared to the...
August 02, 2017 02:00 ET | Source: H. Lundbeck A/S

Lundbeck collaborates on large first-of-its kind study of links between genetics and psychiatric disorders

Valby, 2017-08-02 08:00 CEST (GLOBE NEWSWIRE) -- H. Lundbeck A/S (Lundbeck) joins personal genetics company 23andMe, Inc. and think tank the Milken Institute in a large new study to increase the...
August 02, 2017 02:00 ET | Source: H. Lundbeck A/S

Lundbeck samarbejder om stort banebrydende studie af sammenhænge mellem gener og psykiatriske lidelser

Valby, 2017-08-02 08:00 CEST (GLOBE NEWSWIRE) -- H. Lundbeck A/S (Lundbeck) går sammen med gentest-firmaet 23andMe, Inc. og tænketanken the Milken Institute i et nyt stort studie, som skal øge...
July 28, 2017 10:36 ET | Source: H. Lundbeck A/S

Abilify Maintena® (aripiprazol) godkendes af de amerikanske sundheds-myndigheder (FDA) til vedligeholdelsesbehandling af bipolar I lidelse i monoterapi

Den første FDA-godkendte månedlige, langtidsvirkende, injicerbare behandling til vedligeholdelsesbehandling af bipolar I lidelse I hos voksne1,2 Den nye indikation for Abilify Maintena er...
July 28, 2017 10:36 ET | Source: H. Lundbeck A/S

Abilify Maintena® (aripiprazole) for extended-release injectable suspension approved by the U.S. FDA for maintenance monotherapy treatment of bipolar I disorder

First FDA-approved, once-monthly, long-acting injectable for the maintenance monotherapy treatment of bipolar I disorder in adults1,2 New indication for Abilify Maintena is based on studies...
June 22, 2017 20:30 ET | Source: H. Lundbeck A/S

Lundbeck og Takeda modtager Complete Respose Letter fra de amerikanske sundhedsmyndigheder (FDA) på deres supplerende registreringsansøgning for Trintellix® (vortioxetin)

Valby, Danmark og Osaka, Japan, 23. juni 2017 - H. Lundbeck A/S (Lundbeck) og Takeda Pharmaceutical Company Limited (Takeda) annoncerede i dag, at efter indsendelse af yderligere analyseresultater,...
June 22, 2017 20:30 ET | Source: H. Lundbeck A/S

Lundbeck and Takeda receive Complete Response Letter from the FDA for Trintellix® (vortioxetine) sNDA

Valby, Denmark and Osaka, Japan, 23 June 2017 - H. Lundbeck A/S (Lundbeck) and Takeda Pharmaceutical Company Limited (Takeda) today announced that after providing additional analysis, the U.S. Food...